Gabapentin and the prophylaxis of bipolar disorders in patients intolerant to lithium

Clinical Drug Investigation

Volumn 21, Issue 3, 2001, Pages 169-174

  Mauri, Massimo C ^a,c   Laini, Valerio ^b   Scalvini, Marta E ^a   Omboni, Anna ^a   Ferrari, Veronica M S ^a   Clemente, Alessandra ^a   Salvi, Virginia ^a   Cerveri, Giancarlo ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b BUSTO ARSIZIO HOSPITAL   (Italy)

^c FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GABAPENTIN; LITHIUM;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG TOLERABILITY; FEMALE; HAMILTON SCALE; HUMAN; LEUKOCYTE COUNT; MALE; MANIC DEPRESSIVE PSYCHOSIS; PRIORITY JOURNAL; PROPHYLAXIS; RATING SCALE; RELAPSE; REMISSION; SCORING SYSTEM; SEDATION; TREATMENT OUTCOME; VERTIGO; XEROSTOMIA;

EID: 0035089210     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-200121030-00002     Document Type: Article

References (4)

1. Taylor CP. A summary of mechanistic hypotheses of gabapentin pharmacology. Epilepsy Res 1998; 29: 233-49
2. Chadwick D, Anhut H, Murray G, et al. Gabapentin (GBP: Neurontin) monotherapy in patients with newly diagnosed epilepsy: results of a double blind fixed-dose study comparing three dosages of gabapentin and open-label carbamazepine. Epilepsia 1997; 38 Suppl. 3: 34
3. Morrel M, McLean MJ, Willmore LJ, et al. Efficacy of gabapentin (Neurontin) as add-on therapy for patients with partial epilepsy. Neurology 1997; 4 (3) Suppl. 2: A 335
4. Samkoff LM, Daras M, Tuchman AJ, et al. Amelioration of refractory dysestetic limb pain in multiple sclerosis by gabapentin. Neurology 1997; 49: 304-5